- Login
- Register & Subscribe
- Language: EN FR DE
Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.
The latest MedNous journal. Subscribe to download.
Free Featured Article
Tuesday 30 June 2009
Country: United Kingdom
Alizyme Plc has told investors that there is a “material uncertainty” about whether it will receive milestone payments for one of its drug development programmes. Barring additional funding, it would therefore be unable to continue as a going concern.
The London Stock Exchange-listed company issued the trading update on 29 June 2009.
“The Company does not now expect to have sufficient funding to last beyond the end of August 2009 and will be unable to continue as a going concern without the raising of additional funds. The Company is in discussions with its advisers in relation to such funding. In the absence of additional funds, the Company may face going into administration or liquidation,” the statement said.
Alizyme has two partne
Tuesday 30 June 2009
Country: United Kingdom
Friday 26 June 2009
Country: United Kingdom
Tuesday 23 June 2009
Country: United States
Wednesday 17 June 2009
Country: United States
Visit our news section for more articles.
MedNous is a print publication and a website for medical entrepreneurs in Europe. The name is derived from the Greek word for knowledge – nous – and the English word, medical.
Thursday July 2 2009
Tuesday June 30 2009
Tuesday June 30 2009
Friday June 26 2009
Wednesday June 17 2009